Albemarle (NYSE: ALB) reported Q3 EPS of $2.74, $1.05 worse than the analyst estimate of $3.79. Revenue for the quarter came in at $2.31 billion versus the consensus estimate of $2.53 billion.

GUIDANCE:

Albemarle sees FY2023 EPS of $21.50-$23.50, versus the consensus of $25.99. Albemarle sees FY2023 revenue of $9.5-9.8 billion, versus the consensus of $10.246 billion.

For earnings history and earnings-related data on Albemarle (ALB) click here.